Clinical Trials Logo

Skin Diseases clinical trials

View clinical trials related to Skin Diseases.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 3

NCT ID: NCT04299126 Not yet recruiting - Clinical trials for Disorder of Skin Donor Site

Efficacy and Safety of High Absorption Pad in Split-thickness Skin Graft Donor Site Wound

Start date: March 5, 2020
Phase: N/A
Study type: Interventional

High absorption pad for blood and pus with natural antimicrobial agent or gauze dressing impregnated with paraffin, containing 0.5% chlorhexidine acetate (Bactigras) will be randomly covered on half of split-thickness skin graft donor site wound. The another will be cover on another half of split-thickness skin graft donor site wound. Then, they will be covered with gauzes and bandage. Time to wound healing, amounts of covered dressing gauzes, signs of infection, pain score, erythema index, melanin index, trans epidermal water loss index, and adverse events will be evaluated.

NCT ID: NCT04215458 Not yet recruiting - Fungal Infection Clinical Trials

Microbiota in Skin and Mucosa of Patients With Inflammatory Skin Diseases

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

The pathogeneses of many inflammatory diseases are not completely understood, yet, dysregulation of the human microbiota is increasingly being investigated as a possible contributing factor. The human microbiota includes bacteria, archaea, viruses and fungi. In general, little is known about the fungal colonization in inflammatory skin diseases. This study aims to examine the prevalence of microbiome in skin and oral mucosa of a variety of patients and healthy volunteers visiting the Dermatological outpatient clinic. The study is designed as a case-control study comparing the incidence of colonization or infection in skin and oral mucosa of patients with different skin diseases and healthy volunteers. Patients with selected skin diseases, staff at Zealand University Hospital in Roskilde, relatives to staff and students with relation to the Dermatologic Department will be asked to fill out a short questionnaire and have swaps taken from oral mucosa, as well as skin scrapings and tape strips from lesional skin (only patients) and non-lesional skin (all).

NCT ID: NCT04092413 Not yet recruiting - Nail Diseases Clinical Trials

Subclinical Nail Involvement in Relevant Skin Diseases

Start date: November 1, 2019
Phase:
Study type: Observational

Onychopathies constitute one of the major challenges faced by a dermatologist in terms of its early detection and diagnosis . Many disorders can affect the nails, including deformity and dystrophy, infections, and ingrown toenails. Infections can involve any part of the nail and may or may not change the nail's appearance. Most nail infections are fungal (onychomycosis), but bacterial and viral infections occur .

NCT ID: NCT03976622 Not yet recruiting - Psoriasis Clinical Trials

Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata

INFLAMMAVit
Start date: June 3, 2019
Phase:
Study type: Observational

It is a study of translational research with mechanistically objectives and including biological samples of patients with chronic inflammatory disorders

NCT ID: NCT03578718 Not yet recruiting - Pediatric ALL Clinical Trials

Evaluation of the Interest of a Specialist in Dermatology for Dermatopediatric Consultations

HLSkinPed
Start date: June 25, 2018
Phase:
Study type: Observational

Dermatologic diseases, of very different etiology and variable severity, represent a major motivation for consultation (in private consultations and in emergency departments), thus leading pediatricians to frequently turn to dermatologic advice. The principal aim is to estimate the degree of concordance of the main diagnosis between a pediatrician and a pediatric dermatologist. The secondary aims is to estimate the degree of concordance of the treatment, advices and follow-up.

NCT ID: NCT03485560 Not yet recruiting - Psoriasis Clinical Trials

Revitalization of Damaged Skin Due to Chronic Skin Diseases

Start date: May 1, 2018
Phase: Early Phase 1
Study type: Interventional

Chronic skin disease lead to skin damage and disfiguring to the patient skin. Sometimes, achieving normal skin is not possible by the normal traditional treatment, this study is focusing on use of ACE CSD formula which is mixture of natural peptides and herbs. the main aim is to restore the normal skin appearance for the patient and control the episodes of flare.

NCT ID: NCT03471819 Not yet recruiting - Clinical trials for Dermatologic Disease

Serotonin Levels in Atopic Dermatitis Patients

Start date: April 1, 2018
Phase:
Study type: Observational

Atopic dermatitis (AD) is a chronic pruritic inflammatory skin disease of unknown aetiology. Global prevalence rates range from 1%-20%.AD is often worsened by stress and anxiety.Plasma levels of 5-HT were found to be positively correlated with the disease severity.

NCT ID: NCT03156062 Not yet recruiting - Clinical trials for Papulosquamous Skin Disease

Climatotherapy Versus Topical Combination of Corticosteroids and Salicylic Acid in Treatment of Psoriasis

Start date: July 1, 2017
Phase: N/A
Study type: Interventional

Psoriasis is a multisystem disease predominately manifested as chronic inflammation of the skin and characterized by scaly, erythematous patches, papules and plaques, which are often pruritic. As chronic disease, psoriasis waxes and wanes throughout patient life time. The disease course is modified with initiation and cessation of treatment, and spontaneous remission is rare. Clinically lesions can be distributed in any part of the body, this leads to impaired consequences on the perception of body image, social relations and in general on quality of life.